Media contact: Hannah Echols, echolsh@uab.edu
Markus Buchfellner, M.D.
Marnix E. Heersink School of Medicine
Division of Pediatric Infectious Diseases
Areas of expertise:
- Vaccinations: safe, effective and life saving; schedule for school age kids
- Adenovirus
- Cold and flu in children
- Pediatric Infectious disease outbreaks
Since fall 2021, pediatric physicians at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine and Children’s of Alabama have discovered nine cases of pediatric hepatitis linked to the adenovirus-41 strain identified through bloodwork. The pediatric patients were from across the state of Alabama, and an epidemiological linkage among the patients has not been determined.
The nine pediatric patients, all under age 10, presented with varying degrees of illnesses and liver injury, including liver failure. All patients presented with jaundice, or yellowing of the skin, and were tested and diagnosed with hepatitis. Two patients required liver transplants.
Based on information from UAB and the Alabama Department of Public Health, the CDC issued a health alert encouraging providers presented with pediatric patients with hepatitis of an unknown origin to screen for the adenovirus-41 strain.
The UAB and Children’s team worked with the Alabama Department of Public Health and the Centers for Disease Control and Prevention to issue a health alert regarding their findings. The alert encourages clinicians with pediatric patients with hepatitis of unknown cause to consider testing for the specific adenovirus strain.
“We were able to uncover the possible association with the adenovirus-41 strain because it is our standard practice to screen patients diagnosed with hepatitis for adenovirus,” said Markus Buchfellner, M.D., pediatric infectious diseases physician at UAB and Children’s. “For us to dig deeper into this medical mystery and see if this strain is the cause of these severe hepatitis cases, we first need more data on how widespread the outbreak is.”
Media coverage: